Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HJLI | NOTV | RLMD | ||
| Company | Hancock Jaffe Laboratories Inc | Inotiv Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.71 | 3.50 | 2.85 | ||
| High | 10.75 | 3.82 | 2.97 | ||
| Low | 10.26 | 3.30 | 2.75 | ||
| Last | 10.38 | 3.59 | 2.80 | ||
| Change | -0.21 | +0.18 | +0.05 | ||
| % Change | -1.98% | +5.28% | +1.82% | ||
| Volume | 221,800 | 590,500 | 142,200 | ||
| 20-Day Average Volume | 295,705 | 509,750 | 135,415 | ||
| Previous Close | 10.59 | 3.41 | 2.75 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.16 | 2.55 | 3.23 | ||
| 20-Day Raw Stochastic | 73.54% | 89.28% | 5.22% | ||
| 20-Day Relative Strength | 67.86% | 74.08% | 33.90% | ||
| Weighted Alpha | +9.05 | +3.90 | -24.66 | ||
| Today's Opinion | 88% Buy | 40% Buy | 72% Sell | ||
| Previous Opinion | 88% Buy | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 40% Buy | 40% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.34% since 09/23/21 | +33.96% since 11/15/24 | -6.98% since 11/15/24 | ||
| Low | 9.49 on 09/24/21 | 2.59 on 11/18/24 | 2.73 on 11/21/24 | ||
| High | 11.38 on 09/29/21 | 3.82 on 11/22/24 | 3.22 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +34.98% since 08/30/21 | +103.98% since 10/22/24 | -23.08% since 10/22/24 | ||
| Low | 7.60 on 09/07/21 | 1.64 on 10/25/24 | 2.73 on 11/21/24 | ||
| High | 11.38 on 09/29/21 | 3.82 on 11/22/24 | 3.98 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | +51.09% since 06/30/21 | +136.18% since 08/22/24 | unch since 08/22/24 | ||
| Low | 5.36 on 07/19/21 | 1.23 on 09/11/24 | 2.32 on 09/06/24 | ||
| High | 11.38 on 09/29/21 | 3.82 on 11/22/24 | 3.98 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +62.70% since 03/30/21 | +75.98% since 05/22/24 | -9.39% since 05/22/24 | ||
| Low | 4.99 on 05/13/21 | 1.23 on 09/11/24 | 1.88 on 08/12/24 | ||
| High | 11.38 on 09/29/21 | 3.82 on 11/22/24 | 4.47 on 07/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,146 | 93,354 | 84,487 | ||
| Shares Outstanding, K | 8,685 | 26,004 | 30,174 | ||
| Annual Sales | 0 | 572,430,000 | 0 | ||
| Annual Net Income | -9,140,000 | -105,140,000 | -98,790,000 | ||
| Last Quarter Sales | 0 | 105,790,000 | 0 | ||
| Last Quarter Net Income | -2,380,000 | -26,090,000 | -21,730,000 | ||
| 60-Month Beta | 1.51 | 3.36 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.20 on 08/08/24 | -0.72 on 11/07/24 | ||
| Latest Earnings Date | 11/16/21 | 12/03/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||